Multi-omics reveals that burdock seed aglycone alleviates renal fibrosis by restoring mitochondrial oxidative phosphorylation function
Journal of Proteomics · 2026
DOI: 10.1016/j.jprot.2026.105690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteomics, 2026. Verfasst von Yiduo Luo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Baotou Medical College of Inner Mongolia University of Science and Technology, Baotou 014040, China. Hauptthemen laut MEDLINE: Mitochondria, Oxidative Phosphorylation, Lignans, Arctium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Inner Mongolia Autonomous Region Natural Science Foundation.
Abstract (Originalsprache)
Renal fibrosis (RF), a common pathological process driving chronic kidney disease (CKD) progression to end-stage renal failure, is closely associated with oxidative phosphorylation (OXPHOS). Arctigenin (ATG), the main active component of burdock seed, exhibits anti-inflammatory and anti-fibrotic activities, but its mechanisms in RF treatment remain unclear. Here, we performed integrated transcriptomic and proteomic analyses to identify key targets and pathways of ATG in a unilateral ureteral obstruction-induced rat RF model. Multi-omics enrichment analysis revealed that NDUFS8 and NDUFS2 were the core targets of ATG, with the OXPHOS pathway as the central intersecting pathway. Our results suggest that ATG exerts anti-renal fibrosis effects by targeting the OXPHOS pathway to inhibit excessive reactive oxygen species production and oxidative stress. SIGNIFICANCE: Chronic kidney disease (CKD) continues to impose an escalating global health and socioeconomic burden, while renal fibrosis (RF), as the convergent pathological endpoint of virtually all progressive nephropathies, remains the principal determinant of irreversible renal failure and adverse clinical outcomes. Despite extensive efforts to develop antifibrotic therapies, effective clinical interventions remain elusive, largely due to the complex and multifactorial nature of RF pathogenesis. In this study, we employed an integrated multi-omics framework encompassing transcriptomics, proteomics, and metabolomics to systematically decipher the antifibrotic mechanism of arctigenin (ATG), a bioactive natural compound derived from traditional Chinese medicine. Our findings identify mitochondrial oxidative phosphorylation as the pivotal regulatory axis underlying the renoprotective effects of ATG and further establish key catalytic subunits of mitochondrial complex I as its direct molecular targets. Mechanistically, ATG not only restores complex I activity and reprograms mitochondrial energy metabolism but also preserves the intracellular stability and localization of these subunits, thereby preventing their aberrant release-mediated inflammatory activation and disrupting the self-perpetuating cycle linking metabolic dysfunction, inflammation, and fibrosis progression. Beyond revealing a previously unrecognized dual mechanism integrating metabolic and inflammatory regulation, this study provides compelling evidence that mitochondrial dysfunction is not merely a secondary consequence of tissue injury but a fundamental driver of fibrotic remodeling. Importantly, our work highlights the translational potential of natural product-based mitochondrial interventions for CKD treatment and supports a broader conceptual shift toward metabolism-centered therapeutic strategies for chronic fibrotic diseases. Given the central role of mitochondrial dysfunction across multiple organs, these findings may also have far-reaching implications for the treatment of systemic fibrosis-related disorders beyond the kidney.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Baotou Medical College of Inner Mongolia University of Science and Technology, Baotou 014040, China.
- Shenyang Pharmaceutical University, Shenyang 117004, China.
- Inner Mongolia The Fourth Hospital of Baotou, Baotou 014040, China.
- Inner Mongolia The Fourth Hospital of Baotou, Baotou 014040, China. Electronic address: 2017006513@qq.com.
- Baotou Medical College of Inner Mongolia University of Science and Technology, Baotou 014040, China. Electronic address: 610283014@qq.com.
Förderung
- Inner Mongolia Autonomous Region Natural Science Foundation
Zitieren
APA
Luo, Y., Wu, G., Zhao, L., Bo, Y., Yang, D., Guo, J., Zhao, D., Lv, Y., Tian, Y., Wang, M., Yang, X., & An, M. (2026). Multi-omics reveals that burdock seed aglycone alleviates renal fibrosis by restoring mitochondrial oxidative phosphorylation function. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2026.105690
Vancouver
Luo Y, Wu G, Zhao L, Bo Y, Yang D, Guo J, et al. Multi-omics reveals that burdock seed aglycone alleviates renal fibrosis by restoring mitochondrial oxidative phosphorylation function. Journal of Proteomics. 2026. doi:10.1016/j.jprot.2026.105690
BibTeX
@article{Luo2026,
author = {Luo, Yiduo and Wu, Guodong and Zhao, Longshan and Bo, Yukun and Yang, Dan and Guo, Jingjing and Zhao, Dongdong and Lv, Yanan and Tian, Yi and Wang, Mengyang and Yang, Xuemiao and An, Ming},
title = {Multi-omics reveals that burdock seed aglycone alleviates renal fibrosis by restoring mitochondrial oxidative phosphorylation function},
journal = {Journal of Proteomics},
year = {2026},
doi = {10.1016/j.jprot.2026.105690}
}
EUVIMED